LIVE MARKETS — A health boost for the STOXX

(Adds blog post) STOXX 600 up 0.8% Healthcare stocks lead gains, boosted by 8% jump in Genmab shares Wall St futures steady Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at A Health Boost For The Stoxx Europe's STOXX 600 is up 0.8%, getting a boost from healthcare names which are dominating the top ten biggest gainers in the index. They are being led higher by Denmark-based biotech company Genmab, which has jumped over 8% to its highest in around three years. Genmab and US drugmaker AbbVie on Monday said their combination treatment for patients newly diagnosed with a type of lymphoma reduced the risk of disease progression or death in a late-stage study. An index of European healthcare stocks is up 1.%, on track for its biggest daily rise since mid-September. The rise was enough to put it atop the biggest sectoral gainers, followed by media and banks, which rose 1.4% and 1.2% respectively. Oil and gas was meanwhile the only sector to fall, down 0.2%, as Brent crude futures were a touch lower on the day just below the $100 mark. The DAX and FTSE were also both up around 0.8%, while France's CAC lagged.